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a b s t r a c t
A previously validated cardiovascular system (CVS) model and parameter identiﬁcation method for car-
diac and circulatory disease states are extended and further validated in a porcine model (N = 6) of
induced endotoxic shock with hemoﬁltration. Errors for the identiﬁed model are within 10% when the
model is re-simulated and compared to the clinical data. All identiﬁed parameter trends over time in
the experiments match clinically expected changes both individually and over the cohort. This work rep-
resents a further clinical validation of these model-based cardiovascular diagnosis and therapy guidance
methods for use with monitoring endotoxic disease states.
 2008 Elsevier Inc. All rights reserved.
1. Introduction
Sepsis is a very complex and serious systemic response to infec-
tion that also has a signiﬁcant impact on cardiovascular and circu-
latory performance. Sepsis results in as many deaths in the USA as
out-of-hospital cardiac arrests, and four times the number for
breast cancer [1]. More speciﬁcally, mortality rates have ranged
from 25% to 80% over the last few decades [2]. Septic shock or se-
vere sepsis and multiple organ failure are thus one of the leading
causes for morbidity and mortality in the critical care setting. Since
continuous hemoﬁltration (HF) was ﬁrst described as a new form
of renal replacement therapy [3], a lot of experimental research
has shown that hemoﬁltration can also improve hemodynamics
and survival in septic shock.
This research identiﬁes parameters using a previously described
cardiovascular system (CVS) model and parameter identiﬁcation
process [4–7], using data from a porcine experiment of induced
endotoxic shock, combined with continuous veno-venous hemoﬁl-
tration (CVVH) [8]. Measurements used to identify the model
parameters are the: minimum and maximum volumes in the ven-
tricles (Vlv,Vrv), pressures in aorta, pulmonary artery (Pao,Ppa) and
heart rate (HR). All of these are reasonably measured or estimated
in a critical care setting. Every 30 min into the experiment new
parameters are identiﬁed that uniquely represent the pig’s hemo-
dynamic condition at that time. It is shown that the model is able
to accurately capture all the pressures and volumes when com-
pared to measured clinical data. Every 30 min into the experiment
new parameters are identiﬁed that uniquely represent the pig’s
hemodynamic condition at that time. It is shown that the model
is able to accurately capture all the pressures and volumes when
compared to measured clinical data.
In contrast to other research groups, which mainly use Wind-
kessel models to determine small parts of the circulation (such
as the right ventricular afterload) [9], the CVS model presented
in this research simulates the full circulation. This full representa-
tion of the circulatory system allows the identiﬁcation of all main
physiologically important parameters. For example, the two vascu-
lar resistances Rsys and Rpulin, as well as the resistances to venous
return (Rvr and Rpulout) are available and can be tracked during
the development of septic shock.
The main goal of this research is thus twofold. Firstly, the pre-
viously presented CVS model is further validated – in this research
for septic shock data. This shows the overall validity and applica-
bility of the model and methods developed. Secondly, this research
shows a ﬁrst practical approach for assessing the best therapy in
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sepsis. The model parameters can be used to track the developing
septic condition. For example, tracking systemic vascular resis-
tance (Rsys) in real-time could be an extremely useful tool for a
practitioner. As a result, therapeutic decisions can be optimally
guided. More speciﬁcally, as Rsys drops an optimized dose of vaso-




The CVS model used in this research is a lumped parameter
model previously developed in [10,11], and based on earlier mod-
els [12,13]. The original model consists of six elastic chambers,
with two chambers for the left and right ventricle, respectively,
and has been used in identifying/diagnosing Pulmonary Embolism
[5]. These pressure–volume chambers are each characterized by
the ﬂow in and out of the chamber, the pressure up- and down-
stream, the resistances of the heart valves, and inertia of the
blood – as given for the left ventricle (LV) by the following
equations:
V lv ¼ V lvf þ V spt; ð1Þ
Vpcd ¼ V lv þ V rv; ð2Þ
Ppcd ¼ P0pcd  e
k
pcd VpcdV0pcdð Þ  1
 
; ð3Þ
Pperi ¼ Ppcd þ Pth; ð4Þ
_Q av ¼ ðPlv  Pao  Q av  RavÞLav ; ð5Þ
_Qmt ¼ ðPpu  Plv  Qmt  RmtÞLmt ; ð6Þ
Ppu ¼ Epu  ðVpu  VdpuÞ þ Pth; ð7Þ
Pao ¼ Eao  ðVao  VdaoÞ; ð8Þ
Psys ¼ Esys  ðV sys  VdsysÞ; ð9Þ
Pcap ¼ Ecap  ðVcap  VcapÞ; ð10Þ
_Vpv ¼ Qpulout  Qmt; ð11Þ
_Vao ¼ Q av  Q sys; ð12Þ
_V sys ¼ Q sys  Qvr; ð13Þ

















Plv ¼ Plvf þ Pperi; ð19Þ
Pspt ¼ driS  EessptðV spt  VdsptÞ ð20Þ
þ ð1 driSÞ  P0spt ekspt VsptVosptð Þ  1
 
; ð21Þ
where all abbreviations are explained in Table 2, as also shown in
Fig. 1. Similar equations are obtained for the right ventricle (RV).
The original model [10,11] has been extended previously [6,7]
and an overview of the extended model is given in Fig. 1. The ex-
tended CVS model adds two new compartments (P,V)sys and
(P,V)cap, which represent the systemic and pulmonary capillaries,
respectively. Furthermore, two new resistances, the resistance to
venous return (Rvr) and the outﬂow pulmonary resistance (Rpulout)
were added.
These modiﬁcations are required to allow a more realistic and
physiologically relevant representation of the physiological behav-
ior encountered during mechanical or spontaneous breathing
[7,14]. The vena cava is now also part of the thoracic cavity,
although the aorta and pulmonary capillaries are not included. This
structure is a more physiologically and anatomically accurate rep-
resentation with the pulmonary arteries and veins, as well as the
vena cava, located in the thoracic cavity. However, neither the aor-
ta (as modelled as part of the systemic circulation) nor the lung
capillaries (which are surrounded by alveolar pressure) are sub-
jected by intrathoracic pressure (Pth). More details about the new
model deﬁnition are available in [6,7].
2.2. Integral-based parameter identiﬁcation
The parameter identiﬁcation method used in this research has
been shown to rapidly and accurately identify almost the entire
parameter set in the presence of signiﬁcant measurement noise
[4–6]. This research uses an adjusted identiﬁcation method and
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Fig. 1. Extended CVS model overview which includes additional compartments
(P,V)sys and (P,V)cap to differentiate the arterial and venous sides of the pulmonary
and systemic circulation.
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summarized hereafter. Table 1 lists all the model variables and
states that must be either measured, estimated or identiﬁed from
measured data. Consider the CVS model where, for example Vao
is given by:
VaoðtÞ  Vao0 ¼
Z t
0
ðQav  Q sysÞdt: ð22Þ
Using Eq. (22), the equation deﬁning the pressure in the aorta, Pao,
can be rewritten as:
PaoðtÞ ¼ Pao0 þ Eao 
Z t
0
ðQ av  Q sysÞdt; ð23Þ
which after substituting the equation for Qsys into Eq. (23) and reor-















CA ¼ Pao  Pao0ð Þ; ð24Þ
with A1 ¼ EaoRsys and A2 ¼ EaoRsys. Similarly, the following matrices are ob-
tained for Epa, Evc, Epu, Ecap, Esys, Rsys, Rpulin, Rvr and Rpulout. Note, that
for reasons of simplicity and clarity, the differential dt and the
upper and lower limits of the integration symbol
R
are omitted.
Usually and if not stated otherwise, the integration is done over
one heart beat. In cases where matrices are constructed separately















CA ¼ Ppa  Ppa0ð Þ; ð25Þ















CA ¼ R Pao ; ð26Þ












CA ¼ R Ppa ; ð27Þ












CA ¼ R Psys  R Pth ; ð28Þ












CA ¼ R Pcap  R Pth ; ð29Þ
with A8 ¼ RpuloutEpu .
2.2.1. Extended integral-based identiﬁcation
The main adjustments to the identiﬁcation method, originally
presented in [4], include keeping the elastances (Eao,Epa) ﬁxed at
estimated values, thus allowing other parameters to be more easily
and accurately identiﬁed. The elastances Eao and Epa in the CVS
model are now estimated (assuming zero unstressed volumes Vdao
and Vdpa) [6]:
Eao ¼ 1:25  PPaoSV ; ð30Þ
Epa ¼ 1:25  PPpaSV ; ð31Þ
where PPao and PPpa are the measured arterial and pulmonary artery
pulse pressures and SV is the stroke volume. Importantly, the effect
of a slightly over- or underestimated value for Eao and Epa will can-
cel as the trends over time of these elastances are what is clinically
important, rather than their absolute values. Furthermore, as Eao is








ðPao  Pao0 
R




Pao  Rsys 
R



















Ppa  Rpulin 
R





Using Eqs. (32)–(34) simpliﬁes the parameter identiﬁcation process
as now less parameters have to be identiﬁed, but are directly given
(estimated) or easily calculated. Thus, the identiﬁability of the
parameter set is guaranteed and the identiﬁed parameters are more
reliable and robust and found in a consistent way.
The remaining parameters given in Table 1 are identiﬁed based
on the previously published integral-based identiﬁcation process
[4,5]. Brieﬂy, the following system of linear equations can be
deﬁned:
A ~x ¼~b; ð36Þ
~x ¼ ðLav; Lmt; Ltc; Lpv; Eeslvf ; P0lvf ; Eesrvf ; P0rvf ;
Rav; Rmt; Rtc; Rpv; PopcdÞ>
; ð37Þ
where A is an N  13 matrix, N is the number of integration periods
over which the parameters are constant, ~b is an N  1 vector,~x are
the patient speciﬁc parameters. Eq. (36) can then be solved by linear
least squares to uniquely determine~x.
Constraints can be added, if desired, and matrix A and vector ~b





















and the matrix for the left ventricle during ejection, Alv,eject, is given
by:
Table 1
Parameters used in CVS model
Taken from the literature or measured
Pth, period, klvf, krvf, kspt, kpcd, Eesspt, Vdspt, Vospt, Pospt, Volvf, Vorvf, Vdlvf, Vdrvf, Vdvc,
Vdao, Vdpa, Vdpv
Optimized
Lav, Lmt, Ltc, Lpv, Eeslvf, P0lvf, Eesrvf, P0rvf, Rav, Rmt, Rtc, Rpv, Pao0, Ppu0, Ppa0, Pvc0, P0pcd,
Esys, Ecap, Eao, Epa, Evc, Epu, Rsys, Rpulin, Rpulout, Rvr
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e kpcd  V lvþVrvVopcdð Þð Þ  1
 
: ð43Þ
The matrix for the left ventricle during ﬁlling, Alv,ﬁll, is given by:

















e kpcd  V lvþV rvVopcdð Þð Þ  1
 
: ð47Þ
Vector ~blv;eject for the left ventricle during ejection is given by:
~blv;eject ¼ Pth  ðtðeb : efÞ  tðebÞÞ 
Z
Pao: ð48Þ
Vector ~blv;fill for the left ventricle during ﬁlling is given by:
~blv;fill ¼
Z
Ppu  Pth  ðtðfb : ffÞ  tðfbÞÞ: ð49Þ
Similar equations are obtained for the right ventricle during ﬁlling
and ejection. More detailed information about the derivation and
computation of these terms of the identiﬁcation process can be
found in [4,5].
2.2.2. Scaling process
Given only discrete measurements of peak and minimum val-
ues, the waveforms are not known and the original integral meth-
od of [4] cannot be directly applied. However, waveforms can be
approximately generated by scaling a set of previously calculated
model outputs to best ﬁt the maximum and minimum data values
measured for the pressures and volumes. The assumption is that
these validated model waveforms are reasonably conformable
with the actual clinical case. In addition, because they capture
the maximum and minimum measured values, they also enable
the best ﬁt that the given model can provide.
These scaled signals are then re-identiﬁed using these approx-
imated waveforms and a new CVS forward simulation is per-
formed with the previously identiﬁed parameters to produce a
much closer match to the clinical data than the ﬁrst initial
parameter set. This simulated output is then compared to the
clinical data to assess performance. Subsequently, the output sig-
nals are re-scaled and new parameters are identiﬁed, which are
then again used to run another simulation. This iterative process
is stopped when the relative error between model output and
clinical data reaches a set tolerance or fails to improve. Fig. 2
gives an overview of this overall identiﬁcation process, where
the major change from [4] is the iterative process using scaled,
approximate waveforms in place of difﬁcult to measure clinical
waveforms.
2.2.3. Substitution of ﬂow integrals during the scaling process
Another adjustment to the parameter identiﬁcation process has
been made to better calculate the parameters that are determined
by the ﬂows in and out of the ventricles. Previously, these ﬂows
have been used in the identiﬁcation process and signiﬁcant error









Qpv are now substituted
by their corresponding volumes, as previously presented in [6].
This change has the advantage that the volumes in the ventricles
are measured, or at least estimated signals where the ﬂows them-
selves are not usually directly measured or estimated.
2.3. Experimental protocol and physiological measurements
All experimental procedures for this experiment were reviewed
and approved by the Ethics Committee of the Medical Faculty of
the University of Liège. They were performed in accordance with
the Guide for the Care and Use of Laboratory Animals, as adopted
and promulgated by the US National Institutes of Health (NIH Pub-
lication No. 85-23, revised 1996). The experiments were performed
on six healthy pigs weighing 25–30 kg. All measurements for one
pig and eight measurements of the remaining ﬁve pigs had to be
omitted from the ﬁnal analysis as they contained corrupted data,
such as those produced by disconnected catheters.
The animals were premedicated and anesthetized, as described
previously [9]. Measurements were obtained for systemic arterial
pressure (Pao), pulmonary arterial pressure (Ppa) and the left and
right ventricle pressures and volumes (Plv, Vlv, Prv, Vrv) as described
in [9]. In particular, volume measurements are made by a 7F,
12-electrode (8 mm interelectrode distance) conductance micro-
manometer-tipped catheter (CD Leycom, Zoetermeer, The
Netherlands).
After a 30 min stabilization period, the animals received a
0.5 mg/kg endotoxin infusion (lipopolysaccharide from Escherichia
coli serotype 0127:B8; Sigma Chemical, St. Louis, MO, USA) over a
30 min period (T000–T030). From 60 min (T060) into the experi-
ment onwards, the animals underwent a zero-balance continuous
Choose initial set of parameters
Simulation
Scale output signals to 
measured data









Fig. 2. Parameter identiﬁcation algorithm: (1) a set of parameters is used for an
initial simulation, (2) data are then scaled to match the measured data and (3)
identiﬁed. This process is iterated until the simulation output is acceptable.
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veno-venous hemoﬁltration (CVVH) at a rate of 45 ml/kg/h. A
0.7 m2 large-pore (78 Å) membrane with a cutoff of 80 kDa (Sure-
ﬂux FH 70, Nipro, Osaka, Japan) and a Baxter BM 25–BM 14 hemo-
ﬁltration device (Baxter Health Care, Munich, Germany) were used.
Ultraﬁltrate was replaced in the postdilution mode by a bicarbon-
ate-buffered hemoﬁltration ﬂuid (Na+: 150 mM; K+: 3 mM; bicar-
bonate: 30 mM) at a temperature of 37 C.
3. Results
3.1. Identiﬁcation of endotoxic shock
Fig. 3 illustrates the very good matches achieved for one typical
pig in detail. The ﬁrst two subﬁgures ((a) and (b)) show the left and
right ventricle signals at the beginning of the experiment (T000).
The upper panel of the left subﬁgure (LV) shows the clinical (Vlvp)
vs. simulated left ventricle volume (Vlvs) and in the lower panel the
clinical (Plvp) vs. simulated left ventricle pressure (Plvs) and arterial
pressure (Paop,Paos), respectively. The right subﬁgure (RV) illus-
trates the same results for the right ventricle volume (Vrv, upper
panel) and the right ventricle pressure and pulmonary artery pres-
sure (Prv, Ppa, lower panel). The following four subﬁgures ((c)–(f))
show the same signals at 120 min into the experiment and at
240 min. In each case, the matches between pig-speciﬁc, identiﬁed
model and clinical data are qualitatively very good.
Fig. 4 summarizes the results obtained for all identiﬁed times
(from t000 to t240 min) over all pigs and shows the clinically mea-
sured end-diastolic (EDV) and end-systolic (ESV) left ventricle vol-















































































































































































































Fig. 3. Model output (dotted) vs. clinical (solid line) volume and pressure signals for left and right ventricle (LV, RV). The upper panel shows the clinical (p) vs. simulated
ventricle volume (s). The lower panel shows the clinical (p) vs. simulated (s) ventricle and arterial pressure. The results are shown for 0 min (begin), 120 min (middle) and
240 min (end) into the experiment. (a) Time: 0 min, LV (b) time: 0 min, RV (c) time: 120 min, LV (d) time: 120 min, RV (c) time: 240 min, LV (e) time: 240 min, RV.
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umes (solid lines). The crosses and boxes represent the CVS model
simulation output when re-run using the identiﬁed model param-
eters. As can be seen, the model output values match the true clin-
ical values very well with mean absolute percentage errors less
than 3%, which is well within measurement or estimate errors
[15,16]. Fig. 5 shows the same results for the right ventricle vol-
umes, respectively.
Fig. 6 shows the matched systemic arterial systolic and arterial
diastolic pressure values (SAP, DAP). Solid lines represent the clin-
ical measurements and the crosses, boxes the CVS model outputs.
Again, very good matches are obtained with mean absolute per-
centage errors less than 7%.
Fig. 7 shows the same results for the systolic and diastolic pul-
monary artery pressures (SPAP, DPAP), respectively. Note, that the
match between the two signals shows larger errors for measure-
ments 34–38, because the clinically measured Ppa signal went be-
low zero, a non-physiological value that is almost certainly a
measurement error rather than a true measurement. These mea-
surements were thus ignored during the identiﬁcation process,
but represent the kinds of errors that can occasionally occur.
It has to be noted, that during the identiﬁcation process only the
systolic (maximum) and diastolic (minimum) values of the mea-
sured ventricle volume (EDV, ESV) and arterial pressure (SAP,
DAP) are used. The ventricle pressures (Plv,Prv) are not needed in
the identiﬁcation as they are divided into their corresponding vol-
umes (Vlvf and Vrvf) and driver functions as seen in Eqs. (41)–(43)
and (45)–(47). However, it can clearly be seen that relatively good
matches are nevertheless obtained for the ventricle pressures, fur-
ther validating the model and identiﬁcation process.
If desired, the ventricle pressures could easily be matched more
accurately by adjusting the simple activation functions used in the
CVS model [11]. However, this level of accuracy and added modiﬁ-
cation was not intended in this study and is not necessary given
the good match between re-simulated model and clinical data.
Importantly, this study did not intend to accurately match the
pressure and volume waveform shapes, but only the minimum
(diastolic) and maximum (systolic) values. This goal was adopted
because the main focus is to identify the overall macro-hemody-
namic condition, and less interest is thus placed on exactly match-
ing speciﬁc waveforms. For example, exactly matching the dicrotic
notch in the arterial pressure signals was not a goal. These smaller,
less clinically relevant dynamics are often a function of small
unmodelled non-linearities or small non-linearities in patient-spe-
ciﬁc cardiac activation function. In addition, a patient-speciﬁc acti-
vation function would eliminate most of these clinically
insigniﬁcant differences.
Table 3 shows the mean absolute percentage errors for the
identiﬁed minimum and maximum pressure and volume signals






























Pig 1 Pig 2 Pig 3 Pig 4 Pig 5
Fig. 4. Model output (+, h) vs. clinical (solid line) left ventricle volumes for all
identiﬁed times (from t000 to t240 min) over all pigs. The upper line shows the
clinical vs. identiﬁed (+) end-diastolic volume (LVEDV) and the lower line shows


























Pig 1 Pig 2 Pig 3 Pig 4 Pig 5
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nr of measurements/identifications
Fig. 5. Model output (+, h) vs. clinical (solid line) right ventricle volumes for all
identiﬁed times (from t000 to t240 min) over all pigs. The upper line shows the
clinical vs. identiﬁed (+) end-diastolic volume (RVEDV) and the lower line shows
clinical vs. identiﬁed (h) end-systolic volume (RVESV).



























Pig 1 Pig 3Pig 2 Pig 4 Pig 5
Fig. 6. Model output (+, h) vs. clinical (solid line) arterial pressure for all identiﬁed
times (from t000 to t240 min) over all pigs. The upper line shows the clinical vs.
identiﬁed (+) systolic arterial pressure (SAP) and the lower line shows clinical vs.
identiﬁed (h) diastolic arterial pressure (DAP).



























Pig 1 Pig 2 Pig 3 Pig 4 Pig 5
Fig. 7. Model output (+, h) vs. clinical (solid line) pulmonary artery pressure for all
identiﬁed times (from t000 to t240 min) over all pigs. The upper line shows the
clinical vs. identiﬁed (+) systolic pulmonary artery pressure (SPAP) and the lower
line shows clinical vs. identiﬁed (h) diastolic pulmonary artery pressure (DPAP).
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(SAP, SPAP, LVESV, LVEDV, RVEDV, and RVESV) for the identiﬁed
re-simulated model over all pigs. Generally, the errors are well be-
low 10%, which is within measurement noise. However, as men-
tioned before, there are a few larger errors for the pulmonary
artery pressure Ppa, as seen in Fig. 6, that are caused by a suspi-
ciously low non-physiological pressure signal that was ignored.
Fig. 8 shows the mean identiﬁed systemic vascular resistance
(Rsys) over all pigs during the endotoxic shock experiment. This va-
lue is clinically important due to impact of sepsis on blood pres-
sure, where increasing sepsis and septic shock decrease blood
pressure via loss of control over systemic vascular tome and re-
duced resistance. This loss of resistance is clearly evident in
Fig. 8 as the endotoxin experiment proceeds.
4. Discussion
The major ﬁndings of this research are twofold. Firstly, the clin-
ical experimental results obtained previously [8] are matched
using the extended CVS model and parameter identiﬁcation pro-
cess. Secondly, the CVS model and identiﬁcation process are also
further validated by correctly identifying trends observed during
clinical endotoxic shock experiments [17,8,9,18–21]. Additionally,
clinically signiﬁcant changes in systemic vascular resistance (Rsys)
are identiﬁed during the experiment, as shown in Fig. 8. These re-
sults match physiological expectations as low peripheral vascular
resistance are a common sign in sepsis and decreases left ventric-
ular afterload, as also seen in Fig. 6 in reduced arterial pressures.
Clinically, the real time identiﬁcation and tracking of Rsys would
enable accurate determination of when to begin vasopressor ther-
apy. In addition, based on response to an initial dose, the vasopres-
sor dose could also be optimally titrated.
Table 3 summarizes all results for all ﬁve pigs and a total of 38
identiﬁcation periods. Note, that all measurements for one pig and
eight measurements of the remaining ﬁve pigs had to be omitted
from this ﬁnal analysis as they contained corrupted data, such as
those produced by disconnected catheters. These results show that
the extended CVS model is able to capture the essential dynamics
of the porcine CVS response to endotoxic shock and CVVH over a
selection of subjects.
Clinically, these results hold great potential signiﬁcance. For
critical care monitoring, important clinical indications, such as
the systemic resistance (Rsys) can be tracked in real-time. As a re-
sult, therapeutic decisions can be optimally guided. More speciﬁ-
cally, as Rsys drops an optimized dose of vasopressors (as
opposed to inotropic drugs) can be determined and prescribed.
5. Conclusion
The integral-based optimization successfully identiﬁed pig-spe-
ciﬁc parameters for the extended CVSmodel. This further validation
shows the ability of the model to adequately and realistically cap-
ture the impact of pressure–volume changes during endotoxic
Table 2
Abbreviations used in the CVS model
Abbreviation Description
k Parameter in EDPVR
P0 Parameter in EDPVR
lv Left ventricle
rv Right ventricle
lvf Left ventricle free wall
rvf Right ventricle free wall
spt Septum
pcd Pericardium
V0 Volume at zero pressure

















Pao0 Initial pressure (Pao(0)) in arta
Ppa0 Initial pressure (Ppa(0)) in pulmonary artery
Pvc0 Initial pressure (Pvc(0)) in vena cava
Ppu0 Initial pressure (Ppu(0)) in pulmonary vein
Pth Intrathoracic pressure
period Heartbeat period
driL Activation (driver) function for LV
driR Activation (driver) function for RV
driS Activation (driver) function for septum
Table 3
Mean absolute percentage error (l), standard deviation (r) and inter-quartile range (IQR) in % for measured and simulated pressures and volumes over all identiﬁed times and
pigs
SAP SPAP LVEDV LVESV RVEDV RVESV
Difference in % for measured and simulated pressures and volumes
l 3.19 7.01 1.36 2.12 1.18 1.90
r 2.70 5.27 1.00 1.62 1.07 1.53
IQR 3.93 4.54 1.64 2.10 1.19 1.97
Abbreviations: SAP, systolic arterial pressure; SPAP, systolic pulmonary artery pressure; LVEDV, left ventricle end-diastolic volume; LVESV, left ventricle end-systolic volume;
RVEDV, right ventricle end-diastolic volume; and RVESV, right ventricle end-systolic volume.



























Fig. 8. Mean identiﬁed systemic vascular resistance (Rsys) for all ﬁve analyzed pigs
during the endotoxic shock experiment. This value is clinically important due to
impact of sepsis on blood pressure, where increasing sepsis and septic shock
decrease blood pressure via loss of control over systemic vascular tome and reduced
resistance.
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shock and with CVVH. In particular, the model is able to aggregate
diverse measured data into a clear, clinically and physiologically
relevant diagnostic picture as the condition develops.
More speciﬁcally, sepsis is a disease with unique whole body ef-
fects that are often counter-intuitive and in violation of the normal
auto-regulatory actions of the body that it disrupts. As a result, it
represents the most serious and unique challenge to any identiﬁca-
tion method for diagnosis. Hence, this research is the culmination
of the series of previous works [5–7] and represents a ﬁnal method
in both minimal sensor data and maximum difﬁculty.
As discussed, the results thus offer patient-speciﬁc monitoring
of otherwise unmeasurable, but clinically very signiﬁcant, physio-
logical parameters that can lead to improved therapy of care. This
research thus increases conﬁdence in the clinical applicability and
validity of this overall diagnostic monitoring approach preparatory
to initial studies with human subjects.
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